How excellent is Monsanto (now Bayer CropScience), really?

Monsanto began with saccharin—a product later found to be carcinogenic—and engaged in numerous ethically troubling activities, including the Japanese rice bran oil incident, the use of Agent Orange in Vietnam, and the current controversy over dicamba’s alleged carcinogenicity. Labeling these actions as mere ‘business practices’ is nothing more than a cover-up. Some argue that genetically modified (GM) foods are safe, citing decades of global consumption. Yet the issue with GM crops extends far beyond safety concerns—it touches on humanity’s very future. Monsanto, now merged with Bayer, dominates much of the global GM seed market. Its high-priced seeds have inflicted massive losses on developing countries; Indian agricultural experts stated at a GM crop symposium that India loses $8 billion annually due to GM seeds. Moreover, GM crops do not inherently yield higher outputs—they merely exhibit enhanced pesticide resistance. However, they carry risks of dependency and genetic contamination: fields previously planted with GM crops retain residual GM genes, which can cross-pollinate and assimilate non-GM crops, rendering those fields permanently unable to revert to non-GM cultivation. Monsanto has even leveraged this irreversibility to coerce farmers into purchasing its products.

Career News: Wednesday, August 7, 2024 — the 4th day of the 7th lunar month; Start of Autumn

8. Yum China Holdings, Inc. announced its unaudited financial results for the second quarter of 2024. Total revenue for the quarter reached $2.68 billion. Excluding foreign exchange impacts, total revenue increased by 4% year-on-year. Core operating profit rose 12% year-on-year to $275 million. Net income for the quarter amounted to $212 million. As of June 30, 2024, Yum China operated a total of 15,423 restaurants, including 10,931 KFC outlets and 3,504 Pizza Hut locations. During the quarter, Yum China opened 401 net new restaurants, of which 25% were franchised. 9. Daikin Industries, Ltd. reported its consolidated financial results for the first fiscal quarter ended June 30, 2024. Net sales totaled ¥1.251 trillion (approximately $X billion), up 14.3% year-on-year from ¥1.0947 trillion. Operating profit stood at ¥115.4 billion, compared to ¥117.9 billion a year earlier. Net income attributable to owners of parent amounted to ¥63.1 billion, down 21.4% year-on-year from ¥80.3 billion. 10. Mitsubishi Heavy Industries, Ltd. (MHI) announced its consolidated financial results for the first fiscal quarter ended June 30, 2024 (April–June). Revenue totaled ¥1.1115 trillion, up 13% year-on-year from ¥983.9 billion. Net income attributable to owners of parent was ¥62.2 billion, up 17.1% year-on-year from ¥53.1 billion. Segment revenues included: Power Systems—¥391.5 billion; Industrial & Infrastructure—¥175.1 billion; Logistics, Thermal & Drive Systems—¥320.9 billion; and Aerospace & Defense—¥211.7 billion. 11. Suzuki Motor Corporation reported its consolidated financial results for the first fiscal quarter ended June 30, 2024 (April–June). Revenue totaled ¥1.4576 trillion, up 21% year-on-year from ¥1.2044 trillion. Operating profit amounted to ¥157.557 billion, up 60.8% year-on-year from ¥97.979 billion. Net income attributable to owners of parent was ¥114.233 billion, up 57.9% year-on-year from ¥72.366 billion. 12. Saudi Aramco reported its financial results for the second quarter of 2024. Revenue and other income totaled $125.497 billion, up from $119.552 billion a year earlier. Net income amounted to $29.07 billion, down from $30.083 billion a year earlier. 13. Bayer AG reported its financial results for the second quarter of 2024. Quarterly sales: €11.144 billion, up from €11.044 billion a year earlier. Quarterly EBITDA: €2.111 billion, down from €2.527 billion a year earlier. Quarterly net loss: €34 million, improved from a net loss of €1.887 billion a year earlier. Crop Science division sales: €4.981 billion, up from €4.924 billion a year earlier. Pharmaceuticals division sales: €4.605 billion, up from €4.557 billion a year earlier.

India's Bayer CropScience posts nearly 9% rise in Q2 profit

1 day ago

India's Bayer CropScience posted a 9% Q2 profit rise to 1.66 billion rupees, aided by cost efficiencies and corn seed yields, though revenue fell 19.5% due to poor monsoon conditions affecting demand.

reuters

2026-11-03

India's Bayer CropScience posts nearly 9% rise in Q2 profit

India's Bayer CropScience posts nearly 9% rise in Q2 profit

FAQ